The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Open accessAbstract
Both genetic and epigenetic changes contribute to development of human cancer. Oncogenomics has primarily focused on understanding the genetic basis of neoplasia, with less emphasis being placed on the role of epigenetics in tumourigenesis. Genomic alterations in cancer vary between the different types and stages, tissues and individuals. Moreover, genomic change ranges from single nucleotide mutations to gross chromosomal aneuploidy; which may or may not be associated with underlying genomic instability. Collectively, genomic alterations result in widespread deregulation of gene expression profiles and the disruption of signalling networks that control proliferation and cellular functions. In addition to changes in DNA and chromosomes, it has become evident that oncogenomic processes can be profoundly influenced by epigenetic mechanisms. DNA methylation is one of the key epigenetic factors involved in regulation of gene expression and genomic stability, and is biologically necessary for the maintenance of many cellular functions. While there has been considerable progress in understanding the impact of genetic and epigenetic mechanisms in tumourigenesis, there has been little consideration of the importance of the interplay between these two processes. In this review we summarize current understanding of the role of genetic and epigenetic alterations in human cancer. In addition we consider the associated interactions of genetic and epigenetic processes in tumour onset and progression. Furthermore, we provide a model of tumourigenesis that addresses the combined impact of both epigenetic and genetic alterations in cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“Also, maintenance enzyme Dnmt3a and Dnmt3b double knockouts showed a premature lethal phenotype at 4 weeks of age and at the late embryonic stages respectively, as well as lack a of de novo DNA methylation [157].”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984 · cited 1×
“The establishment and maintenance of proper DNA methylation patterns is essential for growth and development, as well as many cellular processes such as imprinting,”
BackgroundRecurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
Environmental epigenomics and disease susceptibility
Jirtle, R. L., & Skinner, M. K. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2045 · Cited by 2,492
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Bernstein, B. E., Meissner, A., & Lander, E. S. (2007) · Cell · doi:10.1016/j.cell.2007.01.033 · Cited by 2,086 · cited 2×
“In contrast, the deregulation of epigenetic patterns leads to induction and propagation of disease states [6].”
BackgroundEUKARYOTIC CYTOSINE METHYLTRANSFERASES
Goll, M. G., & Bestor, T. H. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.010904.153721 · Cited by 2,063
Genetic instability in colorectal cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386623a0 · Cited by 1,986
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1993) · Nature · doi:10.1038/366362a0 · Cited by 1,964
Mobile Elements: Drivers of Genome Evolution
Kazazian, H. H. (2004) · Science · doi:10.1126/science.1089670 · Cited by 1,922 · cited 1×
“As such, DNA methylation is thought to have evolved as a mechanism related to containment of these potentially harmful genomic elements [163].”
BackgroundTsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., & Croce, C. M. (1984) · Science · doi:10.1126/science.6093263 · Cited by 1,769
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90228-3 · Cited by 1,691
Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
Okano, M., Xie, S., & Li, E. (1998) · Nature Genetics · doi:10.1038/890 · Cited by 1,651
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Genetic Pathways to Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070011 · Cited by 1,497
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
Dnmt3L and the Establishment of Maternal Genomic Imprints
Bourc'his, D., Xu, G.-L., Lin, C.-S., Bollman, B., & Bestor, T. H. (2001) · Science · doi:10.1126/science.1065848 · Cited by 1,439
Lewis, J. D., Meehan, R. R., Henzel, W. J., Maurer-Fogy, I., Jeppesen, P., Klein, F., & Bird, A. (1992) · Cell · doi:10.1016/0092-8674(92)90610-o · Cited by 1,371
Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins
Hendrich, B., & Bird, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6538 · Cited by 1,360
Artificial Transmutation of the Gene
Muller, H. J. (1927) · Science · doi:10.1126/science.66.1699.84 · Cited by 1,348
X inactivation, differentiation, and DNA methylation
Riggs, A. D. (1975) · Cytogenetic and Genome Research · doi:10.1159/000130315 · Cited by 1,342
MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin
Nan, X., Campoy, F. J., & Bird, A. (1997) · Cell · doi:10.1016/s0092-8674(00)81887-5 · Cited by 1,275
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
Giacinti, C., & Giordano, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209615 · Cited by 1,216
Transcription of IAP endogenous retroviruses is constrained by cytosine methylation
Walsh, C. P., Chaillet, J. R., & Bestor, T. H. (1998) · Nature Genetics · doi:10.1038/2413 · Cited by 1,105 · cited 1×
“It was shown that the loss of DNA methylation in Dnmt1-/- mice resulted in demethylation and transcriptional activation of intracisternal type A particle (IAP) retroviruses in developing mouse embryos [162].”
BackgroundAmplification of a Novel v- erb B-Related Gene in a Human Mammary Carcinoma
King, C. R., Kraus, M. H., & Aaronson, S. A. (1985) · Science · doi:10.1126/science.2992089 · Cited by 1,072
Hata, K., Okano, M., Lei, H., & Li, E. (2002) · Development · doi:10.1242/dev.129.8.1983 · Cited by 1,039
Artificial transmutation of the gene
Charleston, K. (1996) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 970
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967 · cited 1×
“Another example of the commonly mutated tumour suppressor genes are BRCA1 and BRCA2, which are the only known high penetrance genes involved in breast cancer susceptibility [19, 20].”
BackgroundRules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951 · cited 1×
“It is well-established that an important part of the cancer etiology lies in stepwise accumulation of genetic changes [1].”
BackgroundAlt, F. W., Kellems, R. E., Bertino, J. R., & Schimke, R. T. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34875-5 · Cited by 941
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
Ng, H.-H., Zhang, Y., Hendrich, B., Johnson, C. A., Turner, B. M., Erdjument-Bromage, H., Tempst, P., Reinberg, D., & Bird, A. (1999) · Nature Genetics · doi:10.1038/12659 · Cited by 936
Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene
Mori, Y., Nagse, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T., & Nakamura, Y. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.4.229 · Cited by 932
Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells
Bestor, T., Laudano, A., Mattaliano, R., & Ingram, V. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90122-2 · Cited by 913
Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., & Nelson, W. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11733 · Cited by 838
Genome instability: a mechanistic view of its causes and consequences
Aguilera, A., & Gómez-González, B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2268 · Cited by 804
Press, M. F., Bernstein, L., Thomas, P. A., Meisner, L. F., Zhou, J. Y., Ma, Y., Hung, G., Robinson, R. A., Harris, C., El-Naggar, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2894 · Cited by 802
Genetic instability and darwinian selection in tumours
Cahill, D. P., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01661-x · Cited by 748
The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome
Hansen, R. S., Wijmenga, C., Luo, P., Stanek, A. M., Canfield, T. K., Weemaes, C. M. R., & Gartler, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14412 · Cited by 735
Tsujimoto, Y., Yunis, J., Onorato-Showe, L., Erikson, J., Nowell, P. C., & Croce, C. M. (1984) · Science · doi:10.1126/science.6610211 · Cited by 652
5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes
Rideout, W. M., Coetzee, G. A., Olumi, A. F., & Jones, P. A. (1990) · Science · doi:10.1126/science.1697983 · Cited by 640
Genome Organization, Function, and Imprinting in Prader-Willi and Angelman Syndromes
Nicholls, R. D., & Knepper, J. L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.153 · Cited by 625
DUSTYMILLER, A., CURRAN, T., & VERMA, I. (1984) · Cell · doi:10.1016/0092-8674(84)90073-4 · Cited by 589
The Fos family of transcription factors and their role in tumourigenesis
Milde-Langosch, K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.008 · Cited by 583
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.
Miyoshi, Y., Ando, H., Nagase, H., Nishisho, I., Horii, A., Miki, Y., Mori, T., Utsunomiya, J., Baba, S., & Petersen, G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4452 · Cited by 566
ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISM
Esteller, M. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095832 · Cited by 549
The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor
Prokhortchouk, A., Hendrich, B., Jørgensen, H., Ruzov, A., Wilm, M., Georgiev, G., Bird, A., & Prokhortchouk, E. (2001) · Genes & Development · doi:10.1101/gad.198501 · Cited by 533 · cited 3×
“It acts as a transcriptional repressor, but unlike MeCP2 and MBD2 which bind a single symmetrically methylated CpG, Kiaso requires at least a pair of CpGs [155].”
BackgroundEsteller, M., Tórtola, S., Toyota, M., Capellá, G., Peinado, M. A., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 531
X-CHROMOSOME INACTIVATION IN MAMMALS
Heard, E., Clerc, P., & Avner, P. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.571 · Cited by 525
Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA
Meehan, R., Lewis, J. D., & Bird, A. P. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.19.5085 · Cited by 515
Hypomethylation of ras oncogenes in primary human cancers
Feinberg, A. P., & Vogelstein, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80115-6 · Cited by 514
The significance of unstable chromosomes in colorectal cancer
Rajagopalan, H., Nowak, M. A., Vogelstein, B., & Lengauer, C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1165 · Cited by 502
May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7393 · Cited by 497
Csankovszki, G., Nagy, A., & Jaenisch, R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.4.773 · Cited by 494
Cancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.1997.03550150066037 · Cited by 486
Epigenetics and human disease: translating basic biology into clinical applications
Rodenhiser, D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.050774 · Cited by 473
Activating mutations for the Met tyrosine kinase receptor in human cancer
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., & Vande Woude, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11445 · Cited by 442
Costello, J. F., & Plass, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.5.285 · Cited by 442
p53: Guardian of the Genome and Policeman of the Oncogenes
Efeyan, A., & Serrano, M. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4211 · Cited by 439
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2006) · Journal of Urology · doi:10.1016/s0022-5347(06)00096-6 · Cited by 435
Cloning, expression and chromosome locations of the human DNMT3 gene family
Xie, S., Wang, Z., Okano, M., Nogami, M., Li, Y., He, W.-W., Okumura, K., & Li, E. (1999) · Gene · doi:10.1016/s0378-1119(99)00252-8 · Cited by 432
Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells
Okano, M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.11.2536 · Cited by 423
Smilinich, N. J., Day, C. D., Fitzpatrick, G. V., Caldwell, G. M., Lossie, A. C., Cooper, P. R., Smallwood, A. C., Joyce, J. A., Schofield, P. N., Reik, W., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8064 · Cited by 408
Stankovic, T., Kidd, A. M. J., Sutcliffe, A., McGuire, G. M., Robinson, P., Weber, P., Bedenham, T., Bradwell, A. R., Easton, D. F., Lennox, G. G., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301706 · Cited by 400
Momparler, R. L., & Bovenzi, V. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200005)183:2<145::aid-jcp1>3.0.co;2-v · Cited by 387
The Catenin p120 ctn Interacts with Kaiso, a Novel BTB/POZ Domain Zinc Finger Transcription Factor
Daniel, J. M., & Reynolds, A. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3614 · Cited by 367
Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
Melki, J. R., Vincent, P., & Clark, S. J. (1999) · PubMed · Cited by 359
DNA (cytosine-5)-methyltransferases in mouse cells and tissues. studies with a mechanism-based probe
Yoder, J. A., Soman, N. S., Verdine, G. L., & Bestor, T. H. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1125 · Cited by 359
Tenenhaus, C., Subramaniam, K., Dunn, M. A., & Seydoux, G. (2001) · Genes & Development · doi:10.1101/gad.876201 · Cited by 357
Biology of EWS/ETS fusions in Ewing's family tumors
Arvand, A., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204598 · Cited by 348
DOUBLE MINUTES AND HOMOGENEOUSLY STAINING REGIONS: Gene Amplification in Mammalian Cells
Cowell, J. K. (1982) · Annual Review of Genetics · doi:10.1146/annurev.ge.16.120182.000321 · Cited by 344
Wang, L. L., Gannavarapu, A., Kozinetz, C. A., Levy, M. L., Lewis, R. A., Chintagumpala, M. M., Ruiz-Maldanado, R., Contreras-Ruiz, J., Cunniff, C., Erickson, R. P., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.669 · Cited by 338
Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205597 · Cited by 321
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer
Rauch, T. A., Zhong, X., Wu, X., Wang, M., Kernstine, K. H., Wang, Z., Riggs, A. D., & Pfeifer, G. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710735105 · Cited by 318
Mismatch repair: mechanisms and relationship to cancer susceptibility
Kolodner, R. D. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89087-8 · Cited by 305
Yoshimoto, M., Cunha, I. W., Coudry, R. A., Fonseca, F. P., Torres, C. H., Soares, F. A., & Squire, J. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603924 · Cited by 295
Self-citationBeckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development
Weksberg, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg067 · Cited by 291
Curran, T., MacConnell, W. P., van Straaten, F., & Verma, I. M. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.5.914 · Cited by 276
Conrad Hal Waddington: the last Renaissance biologist?
Slack, J. M. W. (2002) · Nature Reviews Genetics · doi:10.1038/nrg933 · Cited by 267
Davis, C. D., Uthus, E. O., & Finley, J. W. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.12.2903 · Cited by 261
In Vivo Activity of Murine De Novo Methyltransferases, Dnmt3a and Dnmt3b
Hsieh, C.-L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8211 · Cited by 261
(2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4 · Cited by 259
Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama, B., Toguchida, J., Shimizu, T., Ishizaki, K., Sasaki, M. S., Kotoura, Y., & Yamamuro, T. (1994) · PubMed · Cited by 250
Fuchs, B., & Pritchard, D. J. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00007 · Cited by 248
Strand-specific Mismatch Repair in Mammalian Cells
Modrich, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24727 · Cited by 248
Genome-wide hypomethylation in hepatocellular carcinogenesis.
Lin, C. H., Hsieh, S., Sheen, I., Lee, W. C., Chen, T. C., Shyu, W. C., & Liaw, Y. (2001) · PubMed · Cited by 246
Rice, J. C., Massey-Brown, K. S., & Futscher, B. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202086 · Cited by 243
Moore, L. E., Pfeiffer, R. M., Poscablo, C., Real, F. X., Kogevinas, M., Silverman, D., García-Closas, R., Chanock, S., Tardón, A., Serra, C., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70038-x · Cited by 235
The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse
Tate, P., Skarnes, W., & Bird, A. (1996) · Nature Genetics · doi:10.1038/ng0296-205 · Cited by 231
Rodenhuis, S. (1992) · PubMed · Cited by 222
Hypomethylation of DNA in pathological conditions of the human prostate.
Bedford, M. T., & van Helden, P. D. (1987) · PubMed · Cited by 219
Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma
Toguchida, J., Ishizaki, K., Sasaki, M. S., Nakamura, Y., Ikenaga, M., Kato, M., Sugimot, M., Kotoura, Y., & Yamamuro, T. (1989) · Nature · doi:10.1038/338156a0 · Cited by 216
Fujita, N., Takebayashi, S.-I., Okumura, K., Kudo, S., Chiba, T., Saya, H., & Nakao, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6415 · Cited by 214
Pei, L., Melmed, S. K., Scheithauer, B. W., Kovács, K., Benedict, W. F., & Prager, D. (1995) · PubMed · Cited by 212
DNA hypomethylation and unusual chromosome instability in cell lines fromICF syndrome patients
Tuck-Muller, C. M., Narayan, A., Tsien, F., Smeets, D. F. C. M., Sawyer, J., Fiala, E. S., Sohn, O. S., & Ehrlich, M. (2000) · Cytogenetic and Genome Research · doi:10.1159/000015590 · Cited by 209
Hiltunen, M., Alhonen, L. I., Koıstınaho, J., Myöhänen, S., Pääkkönen, M. E., Marin, S., Kosma, V.-M., & Jänne, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970317)70:6<644::aid-ijc3>3.0.co;2-v · Cited by 208
Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma
Kim, Y., Giuliano, A. R., Hatch, K. D., Schneider, A., Nour, M., Dallal, G. E., Selhub, J., & Mason, J. B. (1994) · Cancer · doi:10.1002/1097-0142(19940801)74:3<893::aid-cncr2820740316>3.0.co;2-b · Cited by 196
Roman-Gomez, J., Castillejo, J. A., Jimenez, A., Gonzalez, M. G., Moreno, F., Rodriguez, M. D. C., Barrios, M., Maldonado, J., & Torres, A. (2002) · Blood · doi:10.1182/blood.v99.7.2291 · Cited by 193
RAS and Leukemia: From Basic Mechanisms to Gene-Directed Therapy
Beaupre, D. M., & Kurzrock, R. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1071 · Cited by 192
C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression
Gamberi, G., Benassi, M. S., Bohling, T., Ragazzini, P., Molendini, L., Sollazzo, M. R., Pompetti, F., Merli, M., Magagnoli, G., Balladelli, A., et al. (1998) · Oncology · doi:10.1159/000011912 · Cited by 179
Genomic mechanisms and measurement of structural and numerical instability in cancer cells
Bayani, J., Selvarajah, S., Maire, G., Vukovic, B., Al-Romaih, K. I., Zieleńska, M., & Squire, J. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.006 · Cited by 170
Self-citationK-ras mutations are a relatively late event in the pathogenesis of lung carcinomas
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)98722-m · Cited by 166
Downing, J. R., Head, D. R., Parham, D. M., Douglass, E. C., Hulshof, M., Link, M., Motroni, T., Grier, H. E., Curcio-Brint, A., & Shapiro, D. N. (1993) · PubMed · Cited by 166
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma
Schulz, W. A., Elo, J. P., Florl, A. R., Pennanen, S., Santourlidis, S., Engers, R., Buchardt, M., Seifert, H., & Visakorpi, T. (2002) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10092 · Cited by 165
Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1
Wong, S., & Weber, J. D. (2007) · Biochemical Journal · doi:10.1042/bj20070151 · Cited by 163
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance
Radich, J., Kopecky, K., Willman, C., Weick, J., Head, D., Appelbaum, F., & Collins, S. (1990) · Blood · doi:10.1182/blood.v76.4.801.801 · Cited by 161
Nishigaki, M., Aoyagi, K., Danjoh, I., Fukaya, M., Yanagihara, K., Sakamoto, H., Yoshida, T., & Sasaki, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3340 · Cited by 160
Debate Surges Over the Origins of Genomic Defects in Cancer
Marx, J. L. (2002) · Science · doi:10.1126/science.297.5581.544 · Cited by 151
Tenenhaus, C. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/9024-dx23 · Cited by 150
Wong, N., Lam, W.-C., Lai, P. B. S., Pang, E., Lau, W. Y., & Johnson, P. J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61718-x · Cited by 142
Fischer, J., Palmedo, G., von Knobloch, R., Bugert, P., Prayer-Galetti, T., Pagano, F. C., & Kovács, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201983 · Cited by 141
Guo, W., Lonardo, F., Ueda, T., Kim, T. K., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2<199::aid-ijc7>3.0.co;2-4 · Cited by 140
Chen, L., Neubauer, A., Kurisu, W., Waldman, F. M., Ljung, B., Goodson, W. H., Goldman, E. S., Moore, D. H., Balázs, M., & Liu, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3847 · Cited by 140
Antequera, F., & Bird, A. P. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9118-9_8 · Cited by 136
Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells
Sadiković, B., & Rodenhiser, D. I. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.06.012 · Cited by 135
Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds.
Neuhausen, S. L., & Marshall, C. J. (1994) · PubMed · Cited by 132
Comparison ofp53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma
Gökgöz, N., Wunder, J. S., Mousses, S., Eskandarian, S., Bell, R. S., & Andrulis, I. L. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2181::aid-cncr1561>3.0.co;2-3 · Cited by 131
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer
Al-Kuraya, K. S., Novotny, H., Bavi, P. P., Siraj, A. K., Shahab Uddin, M. S., Ezzat, A. A., Al-Sanea, N. A., Al‐Dayel, F., Almana, H., Sheikh, S. S., et al. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.038281 · Cited by 131
Angelman syndrome: Mimicking conditions and phenotypes
Williams, C. A., Lossie, A. C., Driscoll, D. J., & Unit, T. R. C. P. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1316 · Cited by 128
Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma Multiforme
Hayashi, Y., Ueki, K., Waha, A., Wiestler, O. D., Louis, D. N., & von Deimling, A. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00890.x · Cited by 128
Blais, A., van Oevelen, C. J. C., Margueron, R., Acosta-Alvear, D., & Dynlacht, B. D. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705051 · Cited by 126
Bianco‐Miotto, T. (2000) · Carcinogenesis · doi:10.1093/carcin/21.2.147 · Cited by 124
Boeke, J., Ammerpohl, O., Kegel, S., Moehren, U., & Renkawitz, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005929200 · Cited by 122
Ehrlich, M., Buchanan, K. L., Tsien, F., Jiang, G., Sun, B., Uicker, W., Weemaes, C. M., Smeets, D., Sperling, K., Belohradsky, B. H., et al. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2917 · Cited by 122
TGF-α and EGFR in head and neck cancer
Grandis, J. R., & Tweardy, D. J. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240531027 · Cited by 119
Okoji, R. S., Yu, R. C., Maronpot, R. R., & Froines, J. R. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.777 · Cited by 118
Chromosomal regions involved in the pathogenesis of osteosarcomas
Stock, C., Kager, L., Fink, F., Gadner, H., & Ambros, P. F. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(200007)28:3<329::aid-gcc11>3.0.co;2-f · Cited by 117
Alterations of the p15, p16, and p18 genes in osteosarcoma
Miller, C. W., Aslo, A., Campbell, M. J., Kawamata, N., Lampkin, B. C., & Koeffler, H. P. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00216-2 · Cited by 116
Epigenetic Regulation of the Human Retinoblastoma Tumor Suppressor Gene Promoter by CTCF
Rosa-Velázquez, I. A. D. L., Rincón‐Arano, H., Benítez-Bribiesca, L., & Targa, F. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2024 · Cited by 113
Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma.
Jürgens, B., Schmitz‐Dräger, B. J., & Schulz, W. A. (1996) · PubMed · Cited by 112
ErbB2 expression is correlated with increased survival of patients with osteosarcoma
Akatsuka, T., Wada, T., Kokai, Y., Kawaguchi, S., Isu, K., Yamashiro, K., Yamashita, T., Sawada, N., Yamawaki, S., & Ishii, S. (2002) · Cancer · doi:10.1002/cncr.10360 · Cited by 112
Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes
Hendrich, B., Abbott, C. M., McQueen, H. A., Chambers, D. M., Cross, S. H., & Bird, A. P. (1999) · Mammalian Genome · doi:10.1007/s003359901112 · Cited by 110
Differential methylation of human LINE-1 retrotransposons in malignant cells
Alves, G., Tatro, A. V., & Fanning, T. G. (1996) · Gene · doi:10.1016/0378-1119(96)00205-3 · Cited by 108
Simpson, J. F., Quan, D. E., O’Malley, F. P., Odom‐Maryon, T., & Clarke, P. E. (1997) · Europe PMC (PubMed Central) · Cited by 106
Shann, Y., Cheng, C., Chiao, C.-H., Chen, D.-T., Li, P.-H., & Hsu, M. (2008) · Genome Research · doi:10.1101/gr.070961.107 · Cited by 99
Rice, J. C. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.17.3233 · Cited by 96
Kim, W.-J., Vo, Q. N., Shrivastav, M., Lataxes, T. A., & Brown, K. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205485 · Cited by 94
Molecular Mechanisms in Gliomagenesis
Hulleman, E., & Helin, K. (2005) · Advances in cancer research · doi:10.1016/s0065-230x(05)94001-3 · Cited by 92
Amplification of Dihydrofolate Reductase Genes in Methotrexate-resistant Cultured Mouse CellsPreprint
SCHIMKE, R. T., Alt, F. W., Kellems, R. E., Kaufman, R. J., & Bertino, J. R. (1978) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1978.042.01.067 · Cited by 92
Constitutively Methylated Cp G Dinucleotides as Mutation Hot Spots in the Retinoblastoma Gene (RB1)
Mancini, D. N., Singh, S. M., Ainsworth, P., & Rodenhiser, D. I. (1997) · The American Journal of Human Genetics · doi:10.1086/513898 · Cited by 87
Identification and Functional Characterization of the p66/p68 Components of the MeCP1 Complex
Feng, Q. F., Cao, R., Xia, L., Erdjument‐Bromage, H., Tempst, P., & Zhang, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.536-546.2002 · Cited by 82
Sadiković, B., Andrews, J. D., Carter, D. M., Robinson, J. W., & Rodenhiser, D. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707506200 · Cited by 82
Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas
Vidal, M. J., Loganzo, F., Oliveira, A. R., Hayward, N. K., & Albino, A. P. (1995) · Melanoma Research · doi:10.1097/00008390-199508000-00006 · Cited by 80
Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Castillejo, J. A., Navarro, G., José‐Eneriz, E. S., Gárate, L., Cordeu, L., Cervantes, F., Prósper, F., et al. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.07.021 · Cited by 78
The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
Sublett, J. E., Jeon, I., & Shapiro, D. N. (1995) · PubMed · Cited by 76
Genetic instability and darwinian selection in tumours
Cahill, D. P., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01874-0 · Cited by 76
Butcher, D. T., Mancini‐DiNardo, D., Archer, T., & Rodenhiser, D. I. (2004) · International Journal of Cancer · doi:10.1002/ijc.20324 · Cited by 75
LINE-1: a human transposable element
Singer, M., Krek, V., McMillan, J., Swergold, G. D., & Thayer, R. E. (1993) · Gene · doi:10.1016/0378-1119(93)90064-a · Cited by 71
Goldstein, M., Meller, I., & Orr‐Urtreger, A. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20489 · Cited by 66
A NEW TRANSLOCATION RELATED TO THE PHILADELPHIA CHROMOSOME
Hayata, I., Kakati, S., & Sandberg, A. A. (1973) · The Lancet · doi:10.1016/s0140-6736(73)93346-1 · Cited by 66
Retinoblastoma: From the Two-Hit Hypothesis to Targeted Chemotherapy
MacPherson, D. P., & Dyer, M. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0276 · Cited by 64
A deleted chromosome no. 13 in human retinoblastoma cells: relevance to tumorigenesis
Balaban, G. B., Gilbert, F., Nichols, W. W., Hill, R., Shields, J. A., & Meadows, A. T. (1981) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(81)90091-1 · Cited by 63
Kanoe, H., Nakayama, T., Murakami, H., Hosaka, T., Yamamoto, H., Nakashima, Y., Tsuboyama, T., Nakamura, T., Sasaki, M. S., & Toguchida, J. (1998) · PubMed · Cited by 62
Imprinted Genes and the Coordination of Fetal and Postnatal Growth in Mammals
Reik, W., Davies, K., Dean, W., Kelsey, G., & Constância, M. (2001) · Novartis Foundation symposium · doi:10.1002/0470846666.ch3 · Cited by 59
MYC amplification in breast cancer: a chromogenic in situ hybridisation study
Rodríguez-Pinilla, S. M., Jones, R. L., Lambros, M. B. K., Arriola, E., Savage, K., James, M., Pinder, S. E., & Reis-Filho, J. S. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.043869 · Cited by 59
Epigenetic contributions to cancer metastasis
Rodenhiser, D. I. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9166-2 · Cited by 50
Gorringe, K. L., Chin, S., Pharoah, P. D. P., Staines, J. M., Oliveíra, C., Edwards, P. A., & Caldas, C. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi032 · Cited by 50
Tosi, G. M., Trimarchi, C., Macaluso, M., Sala, D. L., Ciccodicola, A., Lazzi, S., Massaro‐Giordano, M., Caporossi, A., Giordano, A., & Cinti, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208630 · Cited by 45
Mutation analysis of the RECQL4 gene in sporadic osteosarcomas
Nishijo, K., Nakayama, T., Aoyama, T., Okamoto, T., Ishibe, T., Yasura, K., Shima, Y., Shibata, K. R., Tsuboyama, T., Nakamura, T., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20269 · Cited by 45
Hiltunen, M. O., Koıstınaho, J., Alhonen, L. I., Myöhänen, S., Marin, S., Kosma, V.-M., Pääkkönen, M. E., & Jänne, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.522 · Cited by 44
Imprinting centers, chromatin structure, and disease
Soejima, H., & Wagstaff, J. E. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20443 · Cited by 41
Rodenhiser, D. I., Andrews, J. D., Mancini, D. N., Jung, J.-K., & Singh, S. M. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(96)00171-6 · Cited by 38
Schmutzler, R. K., Bierhoff, E., Werkhausen, T., Fimmers, R., Speiser, P., Kubista, E., Krebs, D., Zeillinger, R., Wiestler, O. D., & von Deimling, A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970620)74:3<322::aid-ijc15>3.0.co;2-d · Cited by 35
Sadiković, B., Haines, T. R., Butcher, D. T., & Rodenhiser, D. I. (2004) · Breast Cancer Research · doi:10.1186/bcr799 · Cited by 33
Ten novel RB1 gene mutations in patients with retinoblastoma.
Abouzeid, H., Munier, F. L., Thonney, F., & Schorderet, D. F. (2007) · PubMed · Cited by 23
The ATM gene and susceptibility to childhood T‐cell acute lymphoblastic leukaemia
Takeuchi, S., Koike, M., Park, S., Seriu, T., Bartram, C. R., Taub, H., Williamson, I., Grewal, J., Taguchi, H., & Koeffler, H. P. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00993.x · Cited by 21
Bachman, A. N., Curtin, G. M., Doolittle, D. J., & Goodman, J. I. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj179 · Cited by 21
Kindich, R., Florl, A. R., Kamradt, J., Lehmann, J., Müller, M., Wullich, B., & Schulz, W. A. (2005) · European Urology · doi:10.1016/j.eururo.2005.09.012 · Cited by 16
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk
(1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80120-2 · Cited by 13
Jones, P. A. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227555-1/00067-8 · Cited by 5
Cited by
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
Prasad, S., Gupta, S. C., & Tyagi, A. K. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.03.042 · Cited by 978
Immunity, inflammation and cancer: a leading role for adenosine
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3613 · Cited by 765
Epigenetic transgenerational actions of environmental factors in disease etiology
Skinner, M. K., Manikkam, M., & Guerrero-Bosagna, C. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.007 · Cited by 712
Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010
Adler, S., Basketter, D., Creton, S., Pelkonen, O., van Benthem, J., Zuang, V., Andersen, K. E., Angers-Loustau, A., Aptula, A., Bal-Price, A., et al. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0693-2 · Cited by 584
Metadata
- Authors
- Sadikovic, B., Al-Romaih, K., Squire, J., & Zielenska, M.
- Venue
- Current Genomics
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-09-01
- Volume
- 9
- Issue
- 6
- Pages
- 394-408
- ISSN
- 1389-2029 (ISSN-L)
- OpenAlex
- W2123739134
- Cited by
- 290
- References
- 182
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.